1-5 of 5
Brian Lauritzen
Close
Sort by
Journal Articles

A Novel Next-Generation FVIII Mimetic, Mim8, Has a Favourable Safety Profile. Results from a 26-Week Safety Study in Cynomolgus Monkeys

Brian Lauritzen, Mads Bjelke, Marie Rossen, Mikala Skydsgaard, Marianne Kjalke, PhD, Olle Björkdahl, Stine L Kjellev, PhDDVM
Journal: Blood
Blood (2020) 136 (Supplement 1): 26–27.
https://doi.org/10.1182/blood-2020-137006
Published: 2020
Journal Articles

Concizumab Promotes Hemostasis Via a TF-FVIIa Dependent Mechanism As Shown in a Rabbit Hemophilia Bleeding Model

Brian Lauritzen, Ida Hilden
Journal: Blood
Blood (2016) 128 (22): 1401.
https://doi.org/10.1182/blood.V128.22.1401.1401
Published: 2016
Journal Articles

Hemostatic effect of a monoclonal antibody mAb 2021 blocking the interaction between FXa and TFPI in a rabbit hemophilia model

Ida Hilden, Brian Lauritzen, Brit Binow Sørensen, Jes Thorn Clausen, Christina Jespersgaard, Berit Olsen Krogh, Andrew Neil Bowler, Jens Breinholt, Albrecht Gruhler, L. Anders Svensson, Helle Heibroch Petersen, Lars Christian Petersen, Kristoffer W. Balling, Lene Hansen, Mette Brunsgaard Hermit, Thomas Egebjerg, Birgitte Friederichsen, Mirella Ezban, Søren Erik Bjørn
Journal: Blood
Blood (2012) 119 (24): 5871–5878.
https://doi.org/10.1182/blood-2012-01-401620
Published: 2012
Includes: Supplemental data
Journal Articles

In Vitro Evaluation of the Effect of rFVIIa on Anti Coagulated Human Whole Blood Treated with Abciximab Using Thromboelastography (TEG).

Dorthe Viuff, PhD, Soeren Andersen, PhD, Brian Lauritzen, PhD, Mirella Ezban, PhD
Journal: Blood
Blood (2006) 108 (11): 1114.
https://doi.org/10.1182/blood.V108.11.1114.1114
Published: 2006
Journal Articles

Recombinant Human FVIIa Reduces Heparin and Low Molecular Weight Heparin (LMWH)-Induced Bleeding in Rats.

Brian Lauritzen, Mikael Tranholm, Peter B. Johansen, Mirella Ezban
Journal: Blood
Blood (2005) 106 (11): 2149.
https://doi.org/10.1182/blood.V106.11.2149.2149
Published: 2005